Inventor · disambiguated record
Kazuro Shiomi
Also filed as: SHIOMI KAZURO
9 granted patents·4 pending applications·12 citations·filing 1993–2017
79Inventor score
Top patents by PatentIndex Score
13 records- 0164US5336783ACalpain inhibitor cystamidin A and its productionKITASATO INST·Filed 1993·Granted Aug 9, 1994·9 cites·2 claims
- 0256US8269051B2Wickerol and method for producing the sameOMURA SATOSHI·Filed 2009·Granted Sep 18, 2012·0 cites·5 claims
- 0351US2005148592A1Use of riboflavin and flavin derivatives as chitinase inhibitorsBAYER AG·Filed 2005·Application pending·0 cites
- 0450US6486197B1Substance ft-0554 and process for producing the sameKITASATO INST·Filed 1998·Granted Nov 26, 2002·3 cites·2 claims
- 0548US7541336B2Substance fki-1033 and process for producing the sameKITASATO INST·Filed 2002·Granted Jun 2, 2009·0 cites·3 claims
- 0648US2015166608A1Novel cyclic depsipeptide derivatives and harmful organism control agents comprising the sameMEIJI SEIKA PHARMA CO LTD·Filed 2013·Application pending·0 cites
- 0746US7514455B2Inhibitors against complex II of electron transport systemKITASATO INST·Filed 2002·Granted Apr 7, 2009·0 cites·10 claims
- 0846US7132447B2Substance FKI-1083 and process for producing the sameKITASATO INST·Filed 2001·Granted Nov 7, 2006·0 cites·4 claims
- 0946US6875766B2Use of riboflavin and flavin derivatives as chitinase inhibitorsBAYER AG·Filed 2001·Granted Apr 5, 2005·0 cites·4 claims
- 1046US2002156126A1FT-0554 substance and its productionKITASATO INST·Filed 2002·Application pending·0 cites
- 1145US2017215422A1Novel cyclic depsipeptide derivatives and harmful organism control agents comprising the sameMEIJI SEIKA PHARMA CO LTD·Filed 2017·Application pending·0 cites
- 1244US6835747B1Ft-0554a substances and process for the preparation thereofKITASATO INST·Filed 2000·Granted Dec 28, 2004·0 cites·6 claims
- 1343US9000194B2Mangromicin compound and production method thereforOMURA SATOSHI·Filed 2012·Granted Apr 7, 2015·0 cites·5 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →